BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34500315)

  • 1. Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric study.
    Milliet F; Bozec A; Schiappa R; Viotti J; Modesto A; Dassonville O; Poissonnet G; Guelfucci B; Bizeau A; Vergez S; Dupret-Bories A; Garrel R; Fakhry N; Santini L; Lallemant B; Chambon G; Sudaka A; Peyrade F; Saada-Bouzid E; Benezery K; Jourdan-Soulier F; Chapel F; Sophie Ramay A; Roger P; Galissier T; Coste V; Ben Lakdar A; Guerlain J; Temam S; Mirghani H; Gorphe P; Chamorey E; Culié D
    Oral Oncol; 2021 Nov; 122():105503. PubMed ID: 34500315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric study.
    Milliet F; Bozec A; Schiappa R; Viotti J; Modesto A; Dassonville O; Poissonnet G; Guelfucci B; Bizeau A; Vergez S; Dupret-Bories A; Garrel R; Fakhry N; Santini L; Lallemant B; Chambon G; Sudaka A; Peyrade F; Saada-Bouzid E; Benezery K; Jourdan-Soulier F; Chapel F; Sophie Ramay A; Roger P; Galissier T; Coste V; Ben Lakdar A; Guerlain J; Temam S; Mirghani H; Gorphe P; Chamorey E; Culié D
    Oral Oncol; 2021 Jan; 112():105041. PubMed ID: 33129057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
    Arsa L; Siripoon T; Trachu N; Foyhirun S; Pangpunyakulchai D; Sanpapant S; Jinawath N; Pattaranutaporn P; Jinawath A; Ngamphaiboon N
    BMC Cancer; 2021 May; 21(1):504. PubMed ID: 33957888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
    Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z
    Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV status and second primary tumours in oropharyngeal squamous cell carcinoma.
    Xu CC; Biron VL; Puttagunta L; Seikaly H
    J Otolaryngol Head Neck Surg; 2013 May; 42(1):36. PubMed ID: 23718873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review of Second Primary Oropharyngeal Cancers in Patients With p16+ Oropharyngeal Cancer.
    Bollig CA; Lee DS; Mazul AL; Stepan K; Puram SV; Massa ST; Zenga J; Faden DL; Doering MM; Jackson RS; Pipkorn P
    Otolaryngol Head Neck Surg; 2021 Apr; 164(4):733-740. PubMed ID: 32928026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.
    Benzerdjeb N; Tantot J; Blanchet C; Philouze P; Mekki Y; Lopez J; Devouassoux-Shisheboran M
    Histopathology; 2021 Sep; 79(3):381-390. PubMed ID: 33560536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
    Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
    Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
    Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
    Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
    Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
    Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains.
    Klein S; Quaas A; Quantius J; Löser H; Meinel J; Peifer M; Wagner S; Gattenlöhner S; Wittekindt C; von Knebel Doeberitz M; Prigge ES; Langer C; Noh KW; Maltseva M; Reinhardt HC; Büttner R; Klussmann JP; Wuerdemann N
    Clin Cancer Res; 2021 Feb; 27(4):1131-1138. PubMed ID: 33262137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of p16 and HPV DNA in non-tonsillar, non-base of tongue oropharyngeal cancer.
    Hammarstedt L; Holzhauser S; Zupancic M; Kapoulitsa F; Ursu RG; Ramqvist T; Haeggblom L; Näsman A; Dalianis T; Marklund L
    Acta Otolaryngol; 2021 Jan; 141(1):89-94. PubMed ID: 32940116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of p16
    Wagner S; Prigge ES; Wuerdemann N; Reder H; Bushnak A; Sharma SJ; Obermueller T; von Knebel Doeberitz M; Dreyer T; Gattenlöhner S; Wolf G; Pons-Kühnemann J; Wittekindt C; Klussmann JP
    Br J Cancer; 2020 Sep; 123(7):1114-1122. PubMed ID: 32624580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
    Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
    Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16 overexpression and Rb loss correlate with high-risk HPV infection in oropharyngeal squamous cell carcinoma.
    Jiromaru R; Yamamoto H; Yasumatsu R; Hongo T; Nozaki Y; Nakano T; Hashimoto K; Nakagawa T; Oda Y
    Histopathology; 2021 Sep; 79(3):358-369. PubMed ID: 33450095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
    BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.